FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


14853 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Ciprofloxacin 200mg/100mL intravenous injection solution 100mL premixed bag Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
Ciprofloxacin 200mg/bag injection Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
Ciprofloxacin 2mg/mL Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
ciprofloxacine 2 mg/mL, flacon de 200 mL pour perfusion Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
ciprofloxacine 2 mg/mL, flacon de 50 mL pour perfusion Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
Ciprofloxacin 500mg m/r tablet Ciprofloxacin only product in oral dose form
Ciprofloxacin 500mg prolonged-release oral tablet Ciprofloxacin only product in oral dose form
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)
Circumscribed scleroderma NOS Localised scleroderma
Cisapride 1mg/mL suspension Cisapride 1 mg/mL oral suspension
Cisplatin 50mg powder for infusion solution vial Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Cisplatin 50mg/vial powder for injection Product containing precisely cisplatin 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)
Citalopram hydrobromide 10mg/5mL solution Product containing precisely citalopram (as citalopram hydrobromide) 2 milligram/1 milliliter conventional release oral solution (clinical drug)
Citrate 6.5% conventional release eye drops Citric acid only product
Citrate 6.5% preservative-free eye drops Citric acid only product
allergie au citrate Allergy to citric acid (finding)
Citric acid + potassium citrate + sodium citrate 334mg/550mg/500mg syrup Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug)
Citric acid monohydrate + potassium citrate + sodium citrate 334mg/550mg/500mg syrup Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug)
Citric acid monohydrate + potassium citrate + sodium citrate dihydrate 334mg/550mg/500mg syrup Product containing precisely citric acid 66.8 milligram/1 milliliter and potassium citrate 110 milligram/1 milliliter and sodium citrate 100 milligram/1 milliliter conventional release oral solution (clinical drug)
Citrobacter amalonaticus, biogroup 1 Citrobacter farmeri
Citrobacter diversus Citrobacter koseri
Citrullinemia, late-onset type Late-onset citrullinemia type I
Civil engineering technician (general) Civil engineering technician
Cladribine 1mg/mL infusion concentrate 10mL vial Cladribine 1 mg/mL solution for injection
Cladribine 1mg/mL injection Cladribine 1 mg/mL solution for injection
Cladribine 1mg/mL injection solution 10mL vial Cladribine 1 mg/mL solution for injection
Clam - dietary Clam (substance)
Clarithromycin 500mg tablet and lansoprazole 30mg capsule and amoxycillin 500mg capsule pack Amoxicillin 500 mg oral capsule
Classis Archaeobacteria Domain Archaea
Class Cestoidea - subclass cestoda Subclass Eucestoda (organism)
Class Chloroflexi Class Chloroflexia (organism)
Class Eurotiomycetes Subclass Eurotiomycetidae (organism)
Classis Fibrobacteres Class Fibrobacteria
Classis Lentisphaerae Class Lentisphaeria (organism)
Class Microsporea Phylum Microsporidia (organism)
Class amphibia Class Amphibia (organism)
Class arachnida Arachnid
Class crustacea Subphylum Crustacea (organism)
Class diplopoda Class Diplopoda (organism)
Classic SEMM laparoscopic hysterectomy Classic intrafascial supracervical hysterectomy (procedure)
leucémie mastocytaire classique Mast cell leukemia (clinical)
Clavicular flap Flap (substance)
Clavulanate potassium + ticarcillin disodium gm/gm injection Product containing clavulanic acid and ticarcillin (medicinal product)
Clavulanate potassium gm/ticarcillin disodium gm injection solution vial Product containing clavulanic acid and ticarcillin (medicinal product)
environnement propre Clean environment (finding)
Cleaner for heated surfaces Cleaning agent (substance)
Cleaner for heated surfaces causing toxic effect Cleaning product causing toxic effect
produit de nettoyage Cleaning agent (substance)
Cleaning of animal penis Cleaning of penis
Clear cell (mesonephroid) neoplasm - category Clear cell mesonephroid neoplasm
Clear cell sarcoma (except of Kidney M-89643) Clear cell sarcoma
Clemastine 1.34mg tablet Clemastine fumarate 1.34 mg oral tablet
Clemastine 500micrograms/5mL elixir Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine fumarate 0.67mg/5mL syrup Product containing precisely clemastine fumarate 134 microgram/1 milliliter conventional release oral solution (clinical drug)
Clemastine+phenylpropanolamine 0.5/25mg tablet Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemastine+phenylpropanolamine 0.5/25mg tablet Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet
Clemmys insculpta Glyptemys insculpta (organism)
Clindamycin 1% topical foam Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug)
Clindamycin 1.2%/tretinoin 0.025% topical gel Clindamycin phosphate 12 mg/g and tretinoin 250 microgram/g cutaneous gel
Clindamycin 2% cream Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clindamycin 75mg/mL oral solution Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75 mg/ 5mL suspension Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin palmitate hydroc 75mg/5mL solution Clindamycin (as clindamycin hydrochloride) 75 mg/mL oral suspension
Clindamycin phosphate 1% solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 100mg vaginal ovule Product containing precisely clindamycin (as clindamycin phosphate) 100 milligram/1 each conventional release vaginal pessary (clinical drug)
Clindamycin phosphate 10mg solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 10mg/mL solution Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous solution
Clindamycin phosphate 2% cream Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug)
Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress score Clinical Outcomes in Routine Evaluation Outcome Measure Global Distress total score
Clinical actions A - G Action
Clinical actions A-O Action
Clinical actions H - O Action
Clinical actions P - S Action
Clinical actions P-Z Action
Clinical actions T - Z Action
Clinical finding Clinical finding (finding)
Clinical management plan Clinical management plan
Clinical stage 0 0
stade clinique I A IA
stade clinique I B IB
stade clinique I C IC
stade clinique I E IE
stade clinique I S American Joint Committee on Cancer stage IS (qualifier value)
stade clinique II A American Joint Committee on Cancer stage IIA (qualifier value)
stade clinique II B American Joint Committee on Cancer stage IIB (qualifier value)
stade clinique II C IIC
stade clinique II E IIE
stade clinique III A American Joint Committee on Cancer stage IIIA (qualifier value)
stade clinique III B American Joint Committee on Cancer stage IIIB (qualifier value)
stade clinique III C American Joint Committee on Cancer stage IIIC (qualifier value)
stade clinique IV A American Joint Committee on Cancer stage IVA (qualifier value)
stade clinique IV B IVB
stade clinique IV C American Joint Committee on Cancer stage IVC (qualifier value)
Clinically relevant enzymes with no Enzyme Commission designation Enzyme
Clipping of organ NOC Closure by clip
Clomocycline sodium adverse reaction Adverse reaction to clomocycline
Clonazepam 0.125mg wafer Product containing precisely clonazepam 125 microgram/1 each conventional release orodispersible tablet (clinical drug)
Clonazepam 0.25mg wafer Clonazepam 250 microgram orodispersible tablet
Clonazepam 0.5mg wafer Clonazepam 500 microgram orodispersible tablet
Clonazepam 1mg wafer Clonazepam 1 mg orodispersible tablet
Clonazepam 2mg wafer Clonazepam 2 mg orodispersible tablet

Start Previous Page 23 of 149 Next End


Reference Sets

Reference set descriptor

Back to Start